24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Debt
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:46
High-tech entrepreneur Moshe Yanai’s debts balloon to $250 million
21:24
"A Robin Hood movement to help the smaller developers": How Appcharge is fighting app store monopolies
17:13
Full list of Israeli high-tech funding rounds in 2026
17:09
Israeli startup bets on psychedelic mushrooms for mental health treatment
More stories
Buzz
Most popular
Daily
Weekly
1
The 50 most promising Israeli startups - 2026
2
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
3
Five bidders advance in Nice’s $2.5 billion Actimize sale process
4
“Israel will remain a cyber powerhouse for the next decade”
5
SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread
More news
Debt
3 stories about Debt
Teva to Unveil Strategic Plan, Layoffs Thursday
12.12.17
|
Dror Reich
Last month the debt-riddled drug maker announced a rehabilitation plan amidst rumors of upcoming employee cuts
Fitch Downgrades Teva to Junk Rating
07.11.17
|
Yaniv Rahimi
The U.S. credit agency changed Teva's rating from BBB to BB, with a negative outlook, due to "significant operational stress." The downgrade might affect Teva's ability to take on additional debt
There May Be a Silver Lining to Teva’s Woes
06.11.17
|
Eli Shimony
Analysts have lowered their target price for Teva following the company's less than stellar third quarter reports, but the company can still turn its luck around with new drugs and a willingness to tighten the belt
Previous Articles